Cardiac Status of Children Infected With Human Immunodeficiency Virus Who Are Receiving Long-term Combination Antiretroviral Therapy
Authors:
- Paige L. WilliamsPWPaige L. Williams
- James D. WilkinsonJWJames D. Wilkinson
- Erin C. LeisterELErin C. Leister
- Russell B. Van DykeRDRussell B. Van Dyke
- William T. ShearerWSWilliam T. Shearer
- Kenneth C. RichKRKenneth C. Rich
- Rohan HazraRHRohan Hazra
- Jonathan R. KaltmanJKJonathan R. Kaltman
- Denise L. JacobsonDJDenise L. Jacobson
- Laurie B. DooleyLDLaurie B. Dooley
- Gwendolyn B. ScottGSGwendolyn B. Scott
- 1 June 2013
- journal article
- clinical trial
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 167 (6) , 520-7
Abstract
Prior to contemporary antiretroviral therapies (ARTs), children infected with human immunodeficiency virus (HIV) were more likely to have heart failure. This study suggests that highly active ART (HAART) does not appear to impair heart function. To determine the cardiac effects of prolonged exposure to HAART on HIV-infected children. In the National Institutes of Health-funded Pediatric HIV/AIDS Cohort Study's Adolescent Master Protocol (AMP), we used linear regression models to compare echocardiographic measures. A total of 14 US pediatric HIV clinics. Perinatally HIV-infected children receiving HAART (n = 325), HIV-exposed but uninfected children (n = 189), and HIV-infected (mostly HAART-unexposed) historical pediatric controls from the National Institutes of Health-funded Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2-HIV) Study (n = 70). EXPOSURE Long-term HAART. Echocardiographic measures of left ventricular (LV) function and structure. The 325 AMP HIV-infected children had lower viral loads, higher CD4 counts, and longer durations of ART than did the 70 HIV-infected children from the P2C2-HIV Study (all P < .001). The z scores for LV fractional shortening (a measure of cardiac function) were significantly lower among HIV-infected children from the P2C2-HIV Study than among the AMP HIV-infected group or the 189 AMP HIV-exposed but uninfected controls (P < .05). For HIV-infected children, a lower nadir CD4 percentage and a higher current viral load were associated with significantly lower cardiac function (LV contractility and LV fractional shortening z scores; all P = .001) and an increased LV end-systolic dimension z score (all P < .03). In an interaction analysis by HIV-infected cohort, the HIV-infected children from the P2C2-HIV Study with a longer ART exposure or a lower nadir CD4 percentage had lower mean LV fractional shortening z scores, whereas the mean z scores were relatively constant among AMP HIV-infected children (P < .05 for all interactions). Long-term HAART appears to be cardioprotective for HIV-infected children and adolescents.Keywords
This publication has 33 references indexed in Scilit:
- Cardiac, Aortic, and Pulmonary Arteriopathy in HIV-Infected Children: The Prospective P2C2 HIV Multicenter StudyPediatric and Developmental Pathology, 2004
- Postmortem cardiomegaly and echocardiographic measurements of left ventricular size and function in children infected with the human immunodeficiency virusCardiovascular Pathology, 2003
- Predictors of cardiac morbidity and related mortality in children with acquired immunodeficiency syndromeJACC, 2003
- Cardiovascular risk factors, monitoring, and therapy for HIV-infected patientsAIDS, 2003
- Cardiovascular status of infants and children of women infected with HIV-1 (P 2 C 2 HIV): a cohort studyThe Lancet, 2002
- Dilation of the aortic root in children infected with human immunodeficiency virus type 1: The Prospective P2C2 HIV Multicenter StudyAmerican Heart Journal, 2001
- Human Immunodeficiency Virus-Related Mortality in Infants and Children: Data From the Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV (P2C2) StudyPediatrics, 2001
- CDC growth charts: United States.2000
- Cardiac Morbidity and Related Mortality in Children With HIV InfectionJAMA, 1993
- Identification of human immunodeficiency virus-1 RNA and DNA in the heart of a child with cardiovascular abnormalities and congenital acquired immune deficiency syndromeThe American Journal of Cardiology, 1990